Funder: National Institutes of Health

Due Dates: June 16, 2025 (New) | July 16, 2025 (Renewal/Resubmission/Revision) | September 7, 2025 (AIDS) | October 16, 2025 (New) | November 16, 2025 (Renewal/Resubmission/Revision) | January 7, 2026 (AIDS) | February 16, 2026 (New) | March 16, 2026 (Renewal/Resubmission/Revision) | May 7, 2026 (AIDS) [and more through January 2028]

Funding Amounts: Up to $275,000 direct costs over 2 years; no more than $200,000 in any single year; max project period 2 years.

Summary: Supports early-stage, high-risk, exploratory neuroscience research within the missions of NINDS and NIMH; clinical trials are not allowed.

Key Information: No clinical trials permitted; foreign and domestic applicants eligible; consult program staff for fit with NINDS/NIMH priorities.